https://www.selleckchem.com/pr....oducts/tiplaxtinin-p
implement smoking cessation interventions, monitor trends, and to inform planning and allocation of healthcare resources.Background Pneumonia is a common respiratory disorder, which brings an enormous financial burden to the medical system. However, the current treatment options for pneumonia are limited because of drug resistance and side effects. Our previous study preliminarily confirmed that Yinlai Decoction (YD), a common prescription for pneumonia in clinical practice, can regulate the expression of inflammatory factor
Like
Comment
Share
